Usefulness of UniCAP-Tryptase fluoroimmunoassay in the diagnosis of anaphylaxis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 54, Issue 6, 1999, Pages 602-606

  Enrique, E ^a   Garcia Ortega P ^a   Gaig, P ^a   Richart, C ^a   Sotorra, O ^b  

^a HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^b HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

Author keywords

Allergy diagnosis; Anaphylaxis; Tryptase fluoroimmunoassay

Indexed keywords

CHYMASE; HISTAMINE; TRYPTASE;

ADOLESCENT; ADULT; AGED; ALLERGIC REACTION; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUOROIMMUNOASSAY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; URTICARIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANAPHYLAXIS; BIOLOGICAL MARKERS; CHYMASES; EVALUATION STUDIES; FEMALE; FLUOROIMMUNOASSAY; HUMANS; MALE; MIDDLE AGED; SERINE ENDOPEPTIDASES; TRYPTASES;

EID: 0032966266     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.1999.00882.x     Document Type: Article

References (16)

1. 1. Schwartz LB, Austen KF. The mast cell and mediators of immediate hypersensitivity. In: Samter M, Talmage DW, Frank MM, Claman HN, editors. Immunological diseases. Boston, MA: Little, Brown, 1988:157-201.
2. 2. Schwartz LB, Metcalfe DD, Miller JS, Earl H, Sullivan T. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 1987;316:1622-1626.
3. cRIγ mRNAs in human mast cells and basophils by competitive reverse transcription-polymerase chain reaction. J Immunol 1995;154:5472-5480.
4. 4. Ansari MQ, Zamora JL, Lipscomb MF. Postmortem diagnosis of acute anaphylaxis by serum tryptase analysis. A case report. Am J Clin Pathol 1993;99:101-103.
5. 5. Schwartz LB, Yinginger JW, Miller J, Bokhari R, Dull D. Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest 1989;83:1551-1555.
6. 6. Enander I, Matsson P, Nystrand J, et al. A new radioimmunoassay for human mast cell tryptase using monoclonal antibodies. J Immunol Methods 1991;138:39-46.
7. 7. Ordoqui E, Zubeldía JM, Aranzábal A, et al. Serum tryptase levels in adverse drug reactions. Allergy 1997;52:1102-1105.
8. 8. van der Linden PG, Hack CE, Poortman J, Vivié-Kipp YC, Struyvenherg A, van der Zwan JK. Insect-sting challenge in 138 patients: relation between clinical severity of anaphylaxis and mast cell activation. J Allergy Clin Immunol 1992;90:110-118.
9. 9. Schwartz LB, Bradford TR, Rouse C, et al. Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis. J Allergy Clin Immunol 1994;14:190-204.
10. 10. Tanus T, Mines D, Atkins PC, Levinson AI. Serum tryptase in idiopathic anaphylaxis: a case report and review of the literature. Ann Emerg Med 1994;24:104-107.
11. 11. Wong S, Dykewicz MS, Pattcrson R. Idiopathic anaphylaxis. A clinical summary of 175 patients. Arch Intern Med 1990;150:1323-1328.
12. 12. Stoloff R, Adams SL, Orfan N, et al. Emergency medical recognition and management of idiopathic anaphylaxis. J Emerg Med 1992;10:693-698.
13. 13. Rasp G, Hochastrasser K. Tryptase in nasal fluid is a useful marker of allergic rhinitis. Allergy 1993;48:72-74.
14. 14. Alvarez MJ, Acero S, Mendoza H, Tabar AI. Cuantificación de las concentraciones de triptasa sérica en el diagnóstico de la anafilaxia. Med Clin (Barc) 1998;110:357-358.
15. 15. Schwartz LB, Sakai K, Bradford TR, Ren S, Zweiman B, Worobec A. The α-form of human tryptase is the predominant type present in blood at baseline levels in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest 1995;96:2702-2706.
16. 16. Carjas K, Abernathy C, Schwartz LB. Serum α-tryptase, an update on its use to screen for systemic mastocytosis. J Allergy Clin Immunol 1996;97:269.